I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 8 studies | 28% ± 10% | |
| connective tissue cell | 5 studies | 39% ± 25% | |
| smooth muscle cell | 3 studies | 45% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 8 studies | 28% ± 10% | |
| connective tissue cell | 5 studies | 39% ± 25% | |
| smooth muscle cell | 3 studies | 45% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| uterus | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 3650.60 | 245 / 245 | 100% | 26.99 | 502 / 502 |
| uterus | 100% | 15433.91 | 170 / 170 | 96% | 29.81 | 441 / 459 |
| breast | 99% | 2268.62 | 454 / 459 | 86% | 16.50 | 957 / 1118 |
| ovary | 100% | 7624.24 | 180 / 180 | 81% | 13.40 | 347 / 430 |
| bladder | 95% | 2380.95 | 20 / 21 | 67% | 9.54 | 339 / 504 |
| esophagus | 66% | 587.72 | 960 / 1445 | 91% | 12.81 | 166 / 183 |
| intestine | 72% | 862.33 | 695 / 966 | 68% | 7.10 | 358 / 527 |
| adrenal gland | 91% | 771.38 | 235 / 258 | 26% | 3.67 | 59 / 230 |
| skin | 90% | 1764.96 | 1632 / 1809 | 18% | 1.33 | 86 / 472 |
| stomach | 33% | 302.28 | 117 / 359 | 72% | 7.96 | 206 / 286 |
| lung | 30% | 198.81 | 176 / 578 | 73% | 7.72 | 845 / 1155 |
| adipose | 98% | 2864.19 | 1184 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 14.18 | 44 / 45 |
| pancreas | 12% | 64.91 | 38 / 328 | 86% | 9.63 | 153 / 178 |
| blood vessel | 86% | 885.47 | 1154 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 58% | 439.72 | 380 / 653 | 8% | 1.09 | 48 / 605 |
| kidney | 10% | 71.29 | 9 / 89 | 15% | 1.18 | 139 / 901 |
| muscle | 24% | 142.76 | 189 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 1.19 | 6 / 29 |
| liver | 0% | 3.48 | 1 / 226 | 13% | 1.17 | 54 / 406 |
| brain | 0% | 0.17 | 1 / 2642 | 13% | 1.04 | 94 / 705 |
| heart | 12% | 64.13 | 105 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 4% | 27.86 | 41 / 929 | 0% | 0 | 0 / 0 |
| spleen | 1% | 4.02 | 2 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0009790 | Biological process | embryo development |
| GO_0033687 | Biological process | osteoblast proliferation |
| GO_0060322 | Biological process | head development |
| GO_0060349 | Biological process | bone morphogenesis |
| GO_0042476 | Biological process | odontogenesis |
| GO_0001655 | Biological process | urogenital system development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0001656 | Biological process | metanephros development |
| GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0002062 | Biological process | chondrocyte differentiation |
| GO_0042733 | Biological process | embryonic digit morphogenesis |
| GO_0072498 | Biological process | embryonic skeletal joint development |
| GO_2000648 | Biological process | positive regulation of stem cell proliferation |
| GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
| GO_0072089 | Biological process | stem cell proliferation |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0035115 | Biological process | embryonic forelimb morphogenesis |
| GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
| GO_0060272 | Biological process | embryonic skeletal joint morphogenesis |
| GO_0060021 | Biological process | roof of mouth development |
| GO_0001823 | Biological process | mesonephros development |
| GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0030154 | Biological process | cell differentiation |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0042474 | Biological process | middle ear morphogenesis |
| GO_0061029 | Biological process | eyelid development in camera-type eye |
| GO_0030501 | Biological process | positive regulation of bone mineralization |
| GO_0036023 | Biological process | embryonic skeletal limb joint morphogenesis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | OSR2 |
| Protein name | Odd-skipped related transciption factor 2 Protein odd-skipped-related 2 |
| Synonyms | |
| Description | FUNCTION: May be involved in the development of the mandibular molar tooth germ at the bud stage. . |
| Accessions | ENST00000520951.1 ENST00000522510.5 [Q8N2R0-1] E5RGY8 ENST00000518199.1 ENST00000435298.6 [Q8N2R0-2] Q8N2R0 E5RH04 E5RH47 ENST00000297565.9 [Q8N2R0-1] ENST00000523368.5 ENST00000457907.3 [Q8N2R0-3] |
